ATE275565T1 - Verfahren zur herstellung von n6-substituierten deaza-adenosinderivaten - Google Patents
Verfahren zur herstellung von n6-substituierten deaza-adenosinderivatenInfo
- Publication number
- ATE275565T1 ATE275565T1 AT99966299T AT99966299T ATE275565T1 AT E275565 T1 ATE275565 T1 AT E275565T1 AT 99966299 T AT99966299 T AT 99966299T AT 99966299 T AT99966299 T AT 99966299T AT E275565 T1 ATE275565 T1 AT E275565T1
- Authority
- AT
- Austria
- Prior art keywords
- producing
- adenosine derivatives
- substituted
- deaza adenosine
- substituted deaza
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11448698P | 1998-12-31 | 1998-12-31 | |
| US11602899P | 1999-01-15 | 1999-01-15 | |
| PCT/US1999/029841 WO2000040584A2 (en) | 1998-12-31 | 1999-12-15 | Process for preparing n6-substituted deaza-adenosine derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE275565T1 true ATE275565T1 (de) | 2004-09-15 |
Family
ID=26812247
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99966299T ATE275565T1 (de) | 1998-12-31 | 1999-12-15 | Verfahren zur herstellung von n6-substituierten deaza-adenosinderivaten |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6429315B1 (de) |
| EP (1) | EP1140933B1 (de) |
| JP (1) | JP2002534430A (de) |
| KR (1) | KR20010089751A (de) |
| CN (1) | CN1383427A (de) |
| AT (1) | ATE275565T1 (de) |
| AU (1) | AU2187100A (de) |
| BR (1) | BR9917000A (de) |
| CA (1) | CA2358962A1 (de) |
| DE (1) | DE69920045T2 (de) |
| DK (1) | DK1140933T3 (de) |
| ES (1) | ES2228163T3 (de) |
| HK (1) | HK1040239A1 (de) |
| PT (1) | PT1140933E (de) |
| SI (1) | SI1140933T1 (de) |
| WO (1) | WO2000040584A2 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1140933T3 (da) | 1998-12-31 | 2004-12-20 | Aventis Pharma Inc | Fremgangsmåde til fremstilling af N6-substituerede deaza-adenosinderivater |
| GT200500281A (es) * | 2004-10-22 | 2006-04-24 | Novartis Ag | Compuestos organicos. |
| GB0500785D0 (en) * | 2005-01-14 | 2005-02-23 | Novartis Ag | Organic compounds |
| GB0607944D0 (en) * | 2006-04-21 | 2006-05-31 | Novartis Ag | Organic compounds |
| KR20080110925A (ko) | 2006-04-21 | 2008-12-19 | 노파르티스 아게 | 아데노신 ａ２ａ 수용체 효능제로서 사용하기 위한 퓨린 유도체 |
| GB0607948D0 (en) * | 2006-04-21 | 2006-05-31 | Novartis Ag | Organic compounds |
| GB0607953D0 (en) * | 2006-04-21 | 2006-05-31 | Novartis Ag | Organic compounds |
| GB0607950D0 (en) * | 2006-04-21 | 2006-05-31 | Novartis Ag | Organic compounds |
| EP1889846A1 (de) | 2006-07-13 | 2008-02-20 | Novartis AG | Purinderivate als A2a Agonisten |
| EP1903044A1 (de) * | 2006-09-14 | 2008-03-26 | Novartis AG | Adenosinderivate als Agonisten des A2A-Rezeptors |
| BRPI0718792A2 (pt) * | 2006-11-10 | 2013-12-03 | Novartis Ag | Compostos orgânicos |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5652366A (en) | 1990-09-25 | 1997-07-29 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | DI (1R)-(-)camphosulfonic acid) salt, preparation thereof and use thereof |
| US5561134A (en) | 1990-09-25 | 1996-10-01 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties |
| ES2095960T3 (es) | 1990-09-25 | 1997-03-01 | Rhone Poulenc Rorer Int | Compuestos que tienen propiedades antihipertensivas y antiisquemicas. |
| US5545769A (en) | 1994-09-29 | 1996-08-13 | E. I. Du Pont De Nemours And Company | Process for the manufacture of selected halogenated hydrocarbons containing fluorine and hydrogen and compositions provided therein |
| US5684159A (en) | 1995-05-30 | 1997-11-04 | Rhone-Poulenc Rorer S.A. | L-tartaric acid salt of a (1R) diastereomer of a 2-azadihydroxybicyclo 2.2.1!heptane compound and the preparation of 2-azabicyclo 2.2.1!heptane compounds |
| FR2734822B1 (fr) | 1995-05-30 | 1997-07-04 | Rhone Poulenc Rorer Sa | Nouveaux derives du 2-azabicyclo(2.2.1)heptane, leur preparation et leur application |
| CZ203998A3 (cs) | 1996-01-02 | 1999-11-17 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Způsob přípravy 2,4-dihydroxypyridinu a 2,4-dihydroxy-3-nitropyridinu |
| UA51716C2 (uk) * | 1996-07-08 | 2002-12-16 | Авентіс Фармасьютікалз Продактс Інк. | Сполуки, що мають гіпотензивну, кардіопротекторну, анти-ішемічну та антиліполітичну властивості, фармацевтична композиція та способи лікування |
| SK26999A3 (en) | 1996-09-12 | 1999-10-08 | Rhone Poulenc Rorer Pharma | Stereospecific preparation of chiral 1-aryl- and 1-heteroaryl-2- -substituted ethyl-2-amines |
| MXPA03006730A (es) | 1996-12-11 | 2003-10-24 | Aventis Pharma Inc | Preparacion de 4-hidroxi-3-nitro-2(1h)-piridona. |
| DK1140933T3 (da) | 1998-12-31 | 2004-12-20 | Aventis Pharma Inc | Fremgangsmåde til fremstilling af N6-substituerede deaza-adenosinderivater |
-
1999
- 1999-12-15 DK DK99966299T patent/DK1140933T3/da active
- 1999-12-15 ES ES99966299T patent/ES2228163T3/es not_active Expired - Lifetime
- 1999-12-15 AT AT99966299T patent/ATE275565T1/de not_active IP Right Cessation
- 1999-12-15 BR BR9917000-0A patent/BR9917000A/pt not_active IP Right Cessation
- 1999-12-15 DE DE69920045T patent/DE69920045T2/de not_active Expired - Fee Related
- 1999-12-15 CN CN99815953A patent/CN1383427A/zh active Pending
- 1999-12-15 JP JP2000592292A patent/JP2002534430A/ja active Pending
- 1999-12-15 CA CA002358962A patent/CA2358962A1/en not_active Abandoned
- 1999-12-15 EP EP99966299A patent/EP1140933B1/de not_active Expired - Lifetime
- 1999-12-15 WO PCT/US1999/029841 patent/WO2000040584A2/en not_active Application Discontinuation
- 1999-12-15 AU AU21871/00A patent/AU2187100A/en not_active Abandoned
- 1999-12-15 KR KR1020017008416A patent/KR20010089751A/ko not_active Application Discontinuation
- 1999-12-15 SI SI9930688T patent/SI1140933T1/xx unknown
- 1999-12-15 PT PT99966299T patent/PT1140933E/pt unknown
-
2000
- 2000-01-21 US US09/489,276 patent/US6429315B1/en not_active Expired - Fee Related
-
2001
- 2001-11-05 HK HK01107707A patent/HK1040239A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| SI1140933T1 (en) | 2005-02-28 |
| BR9917000A (pt) | 2001-12-11 |
| CN1383427A (zh) | 2002-12-04 |
| WO2000040584A3 (en) | 2000-11-02 |
| ES2228163T3 (es) | 2005-04-01 |
| EP1140933B1 (de) | 2004-09-08 |
| KR20010089751A (ko) | 2001-10-08 |
| US6429315B1 (en) | 2002-08-06 |
| CA2358962A1 (en) | 2000-07-13 |
| DE69920045D1 (de) | 2004-10-14 |
| PT1140933E (pt) | 2004-12-31 |
| JP2002534430A (ja) | 2002-10-15 |
| WO2000040584A2 (en) | 2000-07-13 |
| DE69920045T2 (de) | 2005-09-29 |
| AU2187100A (en) | 2000-07-24 |
| HK1040239A1 (en) | 2002-05-31 |
| DK1140933T3 (da) | 2004-12-20 |
| EP1140933A2 (de) | 2001-10-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE275565T1 (de) | Verfahren zur herstellung von n6-substituierten deaza-adenosinderivaten | |
| ATE194142T1 (de) | Verfahren zur herstellung von nukleotiden | |
| DE69816642D1 (de) | Verfahren zur stereoselektiven synthese von prostacyclin-derivaten | |
| ATE187440T1 (de) | Verfahren zur herstellung von substituierten 3- aminobenzonitrilen | |
| ATE174601T1 (de) | Verfahren zur herstellung von bisnoraldehyden aus bisnoralkohol | |
| DE69931493D1 (de) | Verfahren zur herstellung von hydroxymethylthiobuttersäure | |
| ATE345315T1 (de) | Verfahren zur herstellung von expandiertem graphit | |
| ATE250057T1 (de) | Verfahren zur herstellung von 1-(1h)- benzoquinolizin-3-on derivaten | |
| ATE281434T1 (de) | Verfahren zur herstellung von benzoperhydroisoindolen | |
| ATE277919T1 (de) | Verfahren zur herstellung von baccatin iii- derivativen | |
| DE69812079D1 (de) | Verfahren zur herstellung eines buthylthuio-isochinolinderivates und zwischenprodukte dafür | |
| ATE417131T1 (de) | Verfahren zur herstellung von metallschaumkörpern auf basis von zink | |
| ATE235461T1 (de) | Verfahren zur herstellung von 3-cyano-2,4- dihalogen-5-fluor-benzoesäuren | |
| DE59907056D1 (de) | Verfahren zur herstellung von cyclen | |
| ATE318815T1 (de) | Verfahren zur herstellung von enantiomeren von indol-2,3-dion-3-oximderivaten | |
| DE50103009D1 (de) | Verfahren zur herstellung von 2-alkyl-3-chlorphenolen | |
| ATE425143T1 (de) | Verfahren zur herstellung von indolen | |
| DE69605573D1 (de) | Verfahren zur herstellung von benzo(b)thiophenen | |
| YU51401A (sh) | Postupak za dobijanje n6-supstituisanih derivata deaza-adenozima | |
| ATE248808T1 (de) | Verfahren zur herstellung von aminocyanacetamid | |
| DE69927247D1 (de) | Verfahren zur herstellung von fleischprodukten | |
| ATE282026T1 (de) | Verfahren zur herstellung von halo-4-phenoxy- chinolinen | |
| DE50001638D1 (de) | Verfahren zur herstellung von 4,6-dichlorpyrimidin | |
| DE3864632D1 (de) | Verfahren zur herstellung von chromanderivaten bzw. von d-alpha-tocopherol. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1140933 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |